Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

Clinical trial NCT00220779 · COMPLETED

Trial details

NCT number: NCT00220779
Sponsor: Grifols Therapeutics LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2002-12-01
Primary completion: 2005-02-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.